LAMPERT MARK N

Average Profitability
18.45%
Insider Buys Quantity
11
Insider Buys Sum
$11.29M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of LAMPERT MARK N

The largest purchase of all time was on 2022-06-01 and amounted to 405641 share of Cullinan Oncology, Inc. for $4.46M.

Biography of LAMPERT MARK N

No biography is available at this moment.

2022-08-22PurchaseKymera Therapeutics, Inc.
KYMR
27,117
0.0406%
$26.00$705,042-11.2%
2022-06-13PurchaseRepare Therapeutics Inc.
RPTX
74,666
0.1677%
$12.73$950,498-7.61%
2022-06-10PurchaseOlema Pharmaceuticals, Inc.
OLMA
41,417
0.0972%
$4.03$167,097-8.71%
2022-06-02PurchaseRepare Therapeutics Inc.
RPTX
258,797
0.5989%
$12.29$3.18M-0.63%
2022-06-01PurchaseCullinan Oncology, Inc.
CGEM
405,641
0.8768%
$11.00$4.46M+4.59%
2022-05-26PurchaseKymera Therapeutics, Inc.
KYMR
3,223
0.0065%
$14.78$47,645+102.11%
2022-05-20PurchaseKymera Therapeutics, Inc.
KYMR
5,883
0.0108%
$14.00$82,358+91.99%
2022-05-18PurchaseRepare Therapeutics Inc.
RPTX
5,730
0.0131%
$8.50$48,705+42.21%
2022-05-12PurchaseCullinan Oncology, Inc.
CGEM
17,744
0.0401%
$9.13$162,091+32.33%
2022-05-05PurchaseKymera Therapeutics, Inc.
KYMR
70,439
0.1332%
$19.60$1.38M+40.61%
2022-04-01PurchaseCullinan Oncology, Inc.
CGEM
9,402
0.0205%
$10.75$101,071+8.96%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.